Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL29699595

CNC(=O)c1cncnc1.O=C(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.50
BCAT2 O15382 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
BAZ2B Q9UIF8 1/20 0.38
CTSL P07711 1/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
BRAF P15056 1/20 0.37
LCK P06239 1/20 0.37
KIT P10721 1/20 0.37
SRC P12931 1/20 0.37
MAPK14 Q16539 1/20 0.37
HDAC4 P56524 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
RAF1 P04049 2/20 0.35
ABL1 P00519 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669122 0.87 HCAR2 (0.58) HCAR2BCAT2MKNK1MKNK2BAZ2B
Trifluoroacetic Acid SCHEMBL28310620 0.83 HCAR2 (0.74) HCAR2BCAT2KDM4EALDH1A1PLOD2
Trifluoroacetic Acid SCHEMBL29618256 0.76 HCAR2 (0.50) HCAR2BCAT2MKNK1MKNK2KDM4E
Trifluoroacetic Acid SCHEMBL1786802 0.76 CES1 (0.52) HDAC6HDAC2HDAC8ALDH1A1HPGD
Trifluoroacetic Acid SCHEMBL27698110 0.76 HCAR2 (0.50) HCAR2BCAT2MKNK1MKNK2KDM4E
SCHEMBL2871262 0.73 HCAR2 (0.46) HCAR2BCAT2HDAC6BRAFLCK
SCHEMBL29883112 0.73 HCAR2 (0.46) HCAR2BCAT2MKNK1MKNK2BAZ2B
SCHEMBL14865358 0.73 HCAR2 (0.47) HCAR2BCAT2CTSLHDAC6HDAC2
Trifluoroacetic Acid SCHEMBL30664883 0.73 HDAC2 (0.52) HDAC6HDAC2HDAC8HPGDTSHR
Trifluoroacetic Acid SCHEMBL27505927 0.71 HDAC6 (0.50) HDAC6HDAC2HDAC8HDAC4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820773-B2 Tricyclic compounds ALIGOS THERAPEUTICS, INC. (US) 2023-11-21 US disclosed
US-20220169650-A1 TRICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220169650-A1 TRICYCLIC COMPOUNDS SLC10A1, PKD1, CEL HCAR2 2053/4885BCAT2 1147/4885MKNK1 2508/4885
US-11820773-B2 Tricyclic compounds SLC10A1, PKD1, CEL HCAR2 2053/4885BCAT2 1147/4885MKNK1 2508/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.